Kim J, Kim M, Kim M, Ran Kim E, Hong S, Kyung Chang D
Sci Rep. 2024; 14(1):19926.
PMID: 39198522
PMC: 11358415.
DOI: 10.1038/s41598-024-68372-0.
Liu X, Yang Q, Diao N, Tang J, Huang Z, Gao X
Intest Res. 2024; 22(3):357-368.
PMID: 38712362
PMC: 11309821.
DOI: 10.5217/ir.2023.00106.
Meng W, Fenton C, Johnsen K, Taman H, Florholmen J, Paulssen R
Sci Rep. 2024; 14(1):6789.
PMID: 38514698
PMC: 10957912.
DOI: 10.1038/s41598-024-57440-0.
Kim S, Park S
Korean J Intern Med. 2024; 39(1):2-3.
PMID: 38225820
PMC: 10790042.
DOI: 10.3904/kjim.2023.539.
Pavel C, Diculescu M, Stepan A, Constantinescu G, Sandru V, Tieranu C
J Clin Med. 2024; 13(1).
PMID: 38202296
PMC: 10780018.
DOI: 10.3390/jcm13010289.
Histologic features and predicting prognosis in ulcerative colitis patients with mild endoscopic activity.
Shin S, Kim H, Kim K, Choi C, Moon J, Kim J
Korean J Intern Med. 2023; 39(1):68-76.
PMID: 38086619
PMC: 10790054.
DOI: 10.3904/kjim.2023.167.
Correlation of mucosal healing endpoints with long-term clinical and patient-reported outcomes in ulcerative colitis.
Parkes G, Ungaro R, Danese S, Abreu M, Arenson E, Zhou W
J Gastroenterol. 2023; 58(10):990-1002.
PMID: 37490069
PMC: 10522527.
DOI: 10.1007/s00535-023-02013-7.
Quantitative Phase Imaging Using Digital Holographic Microscopy to Assess the Degree of Intestinal Inflammation in Patients with Ulcerative Colitis.
Bokemeyer A, Buskermolen J, Ketelhut S, Tepasse P, Vollenberg R, Trebicka J
J Clin Med. 2023; 12(12).
PMID: 37373760
PMC: 10299047.
DOI: 10.3390/jcm12124067.
Anti-apoptotic genes and non-coding RNAs are potential outcome predictors for ulcerative colitis.
Meng W, Johnsen K, Fenton C, Florholmen J, Paulssen R
Funct Integr Genomics. 2023; 23(2):165.
PMID: 37199828
PMC: 10195737.
DOI: 10.1007/s10142-023-01099-9.
The treatment principles and targets for intestinal Behcet's disease.
He K, Wu D
Therap Adv Gastroenterol. 2023; 16:17562848231167283.
PMID: 37113192
PMC: 10126606.
DOI: 10.1177/17562848231167283.
Impaired Intestinal Permeability Assessed by Confocal Laser Endomicroscopy-A New Potential Therapeutic Target in Inflammatory Bowel Disease.
Chiriac S, Sfarti C, Minea H, Stanciu C, Cojocariu C, Singeap A
Diagnostics (Basel). 2023; 13(7).
PMID: 37046447
PMC: 10093200.
DOI: 10.3390/diagnostics13071230.
Assessment of the Degree of Variation of Histologic Inflammation in Ulcerative Colitis.
Mikolajczyk A, Cohen N, Watson S, Ackerman M, Goeppinger S, Hart J
Inflamm Bowel Dis. 2022; 29(2):222-227.
PMID: 35436339
PMC: 10686247.
DOI: 10.1093/ibd/izac070.
Relapse From Deep Remission After Therapeutic De-escalation in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Zhang B, Gulati A, Alipour O, Shao L
J Crohns Colitis. 2020; 14(10):1413-1423.
PMID: 32335670
PMC: 7533897.
DOI: 10.1093/ecco-jcc/jjaa087.
Transcriptional Signatures That Define Ulcerative Colitis in Remission.
Fenton C, Taman H, Florholmen J, Sorbye S, Paulssen R
Inflamm Bowel Dis. 2020; 27(1):94-105.
PMID: 32322884
PMC: 7737162.
DOI: 10.1093/ibd/izaa075.
Emerging concepts in non-invasive monitoring of Crohn's disease.
Marlicz W, Skonieczna-Zydecka K, Dabos K, Loniewski I, Koulaouzidis A
Therap Adv Gastroenterol. 2018; 11:1756284818769076.
PMID: 29707039
PMC: 5912292.
DOI: 10.1177/1756284818769076.
Health-Related Quality of Life and Work-Related Outcomes for Patients With Mild-to-Moderate Ulcerative Colitis and Remission Status Following Short-Term and Long-Term Treatment With Multimatrix Mesalamine: A Prospective, Open-Label Study.
Yarlas A, DHaens G, Willian M, Teynor M
Inflamm Bowel Dis. 2018; 24(2):450-463.
PMID: 29361097
PMC: 6176889.
DOI: 10.1093/ibd/izx041.
Enduring Value of Thiopurines for Inflammatory Bowel Disease Therapy.
Korelitz B
Dig Dis Sci. 2016; 62(2):292-293.
PMID: 28025747
DOI: 10.1007/s10620-016-4419-4.
Molecular Analysis of Inflammatory Bowel Disease: Clinically Useful Tools for Diagnosis, Response Prediction, and Monitoring of Targeted Therapy.
Jiang W, Li X
Mol Diagn Ther. 2015; 19(3):141-58.
PMID: 25990388
DOI: 10.1007/s40291-015-0142-7.
Colonoscopic evaluation in ulcerative colitis.
Paine E
Gastroenterol Rep (Oxf). 2014; 2(3):161-8.
PMID: 24879406
PMC: 4124270.
DOI: 10.1093/gastro/gou028.
Histological healing favors lower risk of colon carcinoma in extensive ulcerative colitis.
Korelitz B, Sultan K, Kothari M, Arapos L, Schneider J, Panagopoulos G
World J Gastroenterol. 2014; 20(17):4980-6.
PMID: 24803809
PMC: 4009530.
DOI: 10.3748/wjg.v20.i17.4980.
